1. Home
  2. LYRA vs WETH Comparison

LYRA vs WETH Comparison

Compare LYRA & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • WETH
  • Stock Information
  • Founded
  • LYRA 2005
  • WETH 1992
  • Country
  • LYRA United States
  • WETH China
  • Employees
  • LYRA N/A
  • WETH N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • WETH
  • Sector
  • LYRA Health Care
  • WETH
  • Exchange
  • LYRA Nasdaq
  • WETH Nasdaq
  • Market Cap
  • LYRA 11.3M
  • WETH 10.9M
  • IPO Year
  • LYRA 2020
  • WETH N/A
  • Fundamental
  • Price
  • LYRA $6.41
  • WETH $1.31
  • Analyst Decision
  • LYRA Hold
  • WETH
  • Analyst Count
  • LYRA 1
  • WETH 0
  • Target Price
  • LYRA $16.00
  • WETH N/A
  • AVG Volume (30 Days)
  • LYRA 14.8K
  • WETH 266.7K
  • Earning Date
  • LYRA 11-11-2025
  • WETH 09-10-2025
  • Dividend Yield
  • LYRA N/A
  • WETH N/A
  • EPS Growth
  • LYRA N/A
  • WETH N/A
  • EPS
  • LYRA N/A
  • WETH 0.52
  • Revenue
  • LYRA $770,000.00
  • WETH $42,280,373.00
  • Revenue This Year
  • LYRA N/A
  • WETH N/A
  • Revenue Next Year
  • LYRA $123.46
  • WETH N/A
  • P/E Ratio
  • LYRA N/A
  • WETH $2.56
  • Revenue Growth
  • LYRA N/A
  • WETH 6.48
  • 52 Week Low
  • LYRA $3.81
  • WETH $0.76
  • 52 Week High
  • LYRA $37.50
  • WETH $2.96
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 38.58
  • WETH 66.57
  • Support Level
  • LYRA $6.15
  • WETH $1.15
  • Resistance Level
  • LYRA $6.72
  • WETH $1.23
  • Average True Range (ATR)
  • LYRA 0.38
  • WETH 0.15
  • MACD
  • LYRA -0.01
  • WETH 0.02
  • Stochastic Oscillator
  • LYRA 25.85
  • WETH 76.60

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.

Share on Social Networks: